Mark Schnitzler, PhD
My current research emphasis is in health policy primarily in solid organ transplantation. I have a passion for the development of novel, large-scale databases containing detailed patient records describing health condition, quality of life, the continuum of care delivery, resource utilization and outcomes. Although focused around transplantation, we have data spanning all areas of health and health care in the United States for more than 12 million individuals and I find many opportunities to collaborate with colleagues on projects in areas such as chronic kidney disease, cardiovascular disease, diabetes, infectious disease and liver disease. The central objective of my research is to alleviate the organ shortage, which is a serious public health problem since the majority of patients awaiting transplantation in the United States will die before a suitable organ is found for them.
As Director of Transplant Outcomes and Policy Research, Dr. Schnitzler leads a diverse team of scientists from Saint Louis University and around the country with skills ranging from biostatistics and epidemiology to nephrology, hepatology, and surgery. This program is an expansion of work that began when he was a faculty member at Washington University in Health Administration and Nephrology. His efforts have both led to and been advanced by lobbying and lectures in the US House of Representatives and Senate. He has also aided in the improvement of organ allocation for the United Network of Organ Sharing and helped develop strategies to expand organ availability for Health and Human Services and the Organ Procurement and Transplant Network.
Community and Academic Affiliations
United Mitochondrial Disease Foundation, St. Louis Chapter
Selected Publications or Presentations
(This listing represents a portion of past and active areas of research.)
1. Schnitzler MA, Hollenbeak CS, Cohen DS, Woodward RS, Lowell JA, Singer GG, Tesi RJ, Howard TK, Mohanakumar T, Brennan DC. The Economic Implications of HLA Matching in Cadaveric Renal Transplantation. New England Journal of Medicine 1999;341(19):1440- 1446.
2. Schnitzler MA, Whiting JF, Brennan DC, Lentine KL, Desai NM, Chapman W, Abbott KC, Kalo Z. The life-years saved by a deceased organ donor. Am J Transpl. September 2005;5:2289- 2296.
3. Gaston RS, Danovitch GM, Epstein RA, Kahn JP, Matas AJ, Schnitzler MA. Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transpl.2005;5:1725-1730.
4. Hauptman PJ, Schnitzler MA, Swindle J, Burroughs TE. Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure. JAMA. 2006 Oct 18;296(15):1877-84.
5. Brennan DC, Schnitzler MA. Long-Term Results of Rabbit Antithymocyte Globulin and Basiliximab Induction. New England Journal of Medicine 2008; 359: 1736-1738.
American Society of Transplantation